NCT05678595

Brief Summary

The aim of this study is to evaluate the effects of high intensity laser therapy (HILT) on pain, functional status, hand grip strength and median nerve cross-sectional area in ultrasonography in patients with carpal tunnel syndrome.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2022

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

January 2, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

January 10, 2023

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 23, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 23, 2023

Completed
Last Updated

June 26, 2023

Status Verified

June 1, 2023

Enrollment Period

7 months

First QC Date

January 2, 2023

Last Update Submit

June 23, 2023

Conditions

Keywords

painHigh-intensity laser therapyultrasonography

Outcome Measures

Primary Outcomes (1)

  • Visual Analog Scale (VAS)

    Visual Analog Scale (VAS) is used to measure and monitor the intensity of pain.

    Change from baseline in pain on the VAS at week 2 and week 12 [ Time Frame: Baseline-Week 2- Week 12 ]

Secondary Outcomes (3)

  • Boston Carpal Tunnel Questionnaire

    Change from baseline in pain and disability on the Boston Carpal Tunnel Questionnaire at week 2 and 12.

  • Hand Grip Force Measurement Test

    Baseline- week 2- week 12

  • The cross-sectional area of the median nerve

    Change from baseline in the cross-sectional area of the median nerve at week 2 and week 12.

Study Arms (2)

A hot laser derived from a Nd: YAG laser

ACTIVE COMPARATOR

HILT: A hot laser derived from a Nd: YAG laser has 12 W (watt) and 1064 nm characteristics. The device will administered to the hand wrist area in two steps in the HILT group: phase I and phase II. The application will made utilizing continuous circular movements in both phases I and II. The first five sessions consisted of a 100-second intermittent phase analgesic effect at 8 W and 8 J/cm2 for a total energy of 200 J. The following five sessions consisted of a continuous 11 minutes 6 second bio stimulating effect with a dosage of 3 W 80 J/cm2. Over the course of two weeks, ten treatment sessions of HILT will be given.

Device: high-intensity laser therapyDevice: sham high-intensity laser therapy

sham high-intensity laser therapy

SHAM COMPARATOR

HILT is administered as a placebo for two weeks, 5 sessions a week, for a total of 10 sessions.

Device: high-intensity laser therapyDevice: sham high-intensity laser therapy

Interventions

HILT: A hot laser derived from a Nd: YAG laser has 12 W (watt) and 1064 nm characteristics. The device will administered to the hand wrist area in two steps in the HILT group: phase I and phase II. The application will made utilizing continuous circular movements in both phases I and II. The first five sessions consisted of a 100-second intermittent phase analgesic effect at 8 W and 8 J/cm2 for a total energy of 200 J. The following five sessions consisted of a continuous 11 minutes 6 second bio stimulating effect with a dosage of 3 W 80 J/cm2. Over the course of two weeks, ten treatment sessions of HILT will be given.

A hot laser derived from a Nd: YAG lasersham high-intensity laser therapy

HILT is administered as a placebo for two weeks, 5 sessions a week, for a total of 10 sessions.

A hot laser derived from a Nd: YAG lasersham high-intensity laser therapy

Eligibility Criteria

Age20 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Electrophysiologically mild or moderate CTS
  • Patients who are literate and able to understand verbal instructions in our

You may not qualify if:

  • Diabetes
  • Systemic disorders that may affect treatment such as hypothyroidism, SLE, gout
  • History of polyneuropathy, cervical radiculopathy, brachial plexopathy
  • Injection for the carpal tunnel in the last 1 month
  • History of severe trauma, fracture, operation to both upper extremities at any time
  • Malignancy or history of malignancy
  • Renal failure
  • Peripheral or central nervous system diseases
  • Pregnancy
  • History of physical therapy program for the same hand wrist in the last months.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Banu Ordahan

Konya, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Carpal Tunnel SyndromePain

Condition Hierarchy (Ancestors)

Median NeuropathyMononeuropathiesPeripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesNerve Compression SyndromesCumulative Trauma DisordersSprains and StrainsWounds and InjuriesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • BANU ORDAHAN

    Meram Medical School, Necmettin Erbakan University, Konya, Turkey

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor

Study Record Dates

First Submitted

January 2, 2023

First Posted

January 10, 2023

Study Start

December 1, 2022

Primary Completion

June 23, 2023

Study Completion

June 23, 2023

Last Updated

June 26, 2023

Record last verified: 2023-06

Locations